Streetbeat News

Earnings

CHRW

ESE

FORR

FWRD

IBEX

The article highlights the top 5 industrials stocks considered oversold in Q1, based on their RSI values being near or below 30. These include IBEX Limited, Forrester Research, Inc., ESCO Technologies Inc., Forward Air Corporation, and C.H. Robinson Worldwide, Inc. Each company's recent financial performance and stock price action are briefly discussed, indicating potential buying opportunities for undervalued stocks in the industrials sector.

Portfolio Pulse from Avi Kapoor

February 12, 2024 | 12:34 pm

EFSH

1847 Holdings LLC (EFSH) announced a positive restatement of its subsidiary ICU Eyewear Holdings, Inc.'s financial results for 2021 and 2022, resulting in a $3.6M reduction in operational losses and a $0.64M increase in assets for 2022.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:34 pm

TRMB

Trimble shares are trading lower following the company's announcement of Q1 and FY24 revenue guidance that fell below market estimates.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:30 pm

QQQ

RIVN

SPY

U.S. stock futures showed indecision ahead of key inflation data and earnings reports. Positive tech earnings and crude oil rally lifted markets last week, with major indices reaching new highs. Analysts express optimism but caution over valuations. SPDR S&P 500 ETF Trust and Invesco QQQ ETF saw premarket gains. Rivian Automotive fell on negative analyst action. Companies like Arista Networks, Avis Budget Group, and others are set to report earnings. Crude oil prices and bond yields remained steady.

Portfolio Pulse from Shanthi Rexaline

February 12, 2024 | 12:19 pm

EVBG

LGIH

MAS

VRNS

VVX

Wall Street's most accurate analysts have made new stock picks, with notable mentions including V2X, Inc. (VVX) with a 72% upside, Everbridge, Inc. (EVBG) seeing a 3% upside following its acquisition by Thoma Bravo, Varonis Systems, Inc. (VRNS) with an 8% downside, LGI Homes, Inc. (LGIH) expected to plunge 20%, and Masco Corporation (MAS) with a 12% upside. These ratings come from analysts with an 88% accuracy rate, except for Keith Hughes from Truist Securities who has an 87% accuracy rate.

Portfolio Pulse from Avi Kapoor

February 12, 2024 | 12:15 pm

IMVT

Immunovant reported a Q3 EPS loss of $(0.36), an improvement from the $(0.49) loss per share YoY. The company's cash and cash equivalents stand at approximately $691M.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:11 pm

BIG

Big Lots has released preliminary unaudited results for Q4, indicating that its performance was in line with guidance on comparable sales, gross margin rate, operating expenses, and inventory.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:11 pm

BBGI

Beasley Broadcast Group (BBGI) reported Q4 earnings of $0.21 per share with sales of $65.70M, missing the consensus estimate of $66.05M by 0.53%. This represents an 8.78% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:03 pm

MNDY

Monday.Com (NASDAQ:MNDY) reported Q4 adjusted EPS of $0.65, surpassing the $0.32 estimate, with sales of $202.57M also beating the $197.95M estimate. This represents a significant increase over the previous year's figures.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:03 pm

LRMR

Larimar Therapeutics, Inc. (LRMR) announced positive top-line data from its Phase 2 study of nomlabofusp in Friedreich's ataxia patients. The study showed nomlabofusp was well tolerated and increased frataxin levels in a dose-dependent manner in the 25 mg and 50 mg cohorts. This marks a successful completion of the study, potentially advancing Larimar's position in developing treatments for complex rare diseases.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 12:03 pm